Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 36.55
+0.15 (0.41%)
Jun 27, 2025, 1:30 PM CST
Synmosa Biopharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 16,321 | 14,499 | 14,706 | 16,021 | 7,016 | 6,814 | Upgrade
| |
Market Cap Growth | 1.25% | -1.41% | -8.21% | 128.36% | 2.96% | 20.87% | Upgrade
|
Enterprise Value | 16,981 | 16,554 | 17,100 | 19,459 | 10,892 | 11,385 | Upgrade
|
Last Close Price | 35.85 | 34.31 | 34.42 | 38.85 | 16.82 | 16.03 | Upgrade
|
PE Ratio | 21.44 | 21.18 | 24.72 | 20.05 | 23.09 | 10.68 | Upgrade
|
Forward PE | - | 51.28 | 51.28 | 51.28 | 51.28 | 19.79 | Upgrade
|
PS Ratio | 2.86 | 2.61 | 2.86 | 3.65 | 2.17 | 2.24 | Upgrade
|
PB Ratio | 1.75 | 1.73 | 1.82 | 2.41 | 1.15 | 1.14 | Upgrade
|
P/TBV Ratio | 2.12 | 2.16 | 2.39 | 3.38 | 1.67 | 1.73 | Upgrade
|
P/FCF Ratio | 26.11 | 25.61 | 48.24 | 31.98 | 19.39 | 68.14 | Upgrade
|
P/OCF Ratio | 18.87 | 18.57 | 28.73 | 25.42 | 15.42 | 26.79 | Upgrade
|
EV/Sales Ratio | 2.97 | 2.98 | 3.33 | 4.44 | 3.37 | 3.75 | Upgrade
|
EV/EBITDA Ratio | 15.57 | 15.38 | 18.43 | 25.58 | 22.83 | 25.99 | Upgrade
|
EV/EBIT Ratio | 22.41 | 22.34 | 27.72 | 42.24 | 58.33 | 76.15 | Upgrade
|
EV/FCF Ratio | 27.17 | 29.24 | 56.09 | 38.84 | 30.10 | 113.85 | Upgrade
|
Debt / Equity Ratio | 0.28 | 0.30 | 0.30 | 0.51 | 0.57 | 0.62 | Upgrade
|
Debt / EBITDA Ratio | 2.40 | 2.37 | 2.56 | 4.32 | 7.15 | 8.30 | Upgrade
|
Debt / FCF Ratio | 4.25 | 4.50 | 7.98 | 6.70 | 9.57 | 37.02 | Upgrade
|
Asset Turnover | 0.45 | 0.46 | 0.45 | 0.41 | 0.31 | 0.32 | Upgrade
|
Inventory Turnover | 1.81 | 1.83 | 1.99 | 1.97 | 1.59 | 1.74 | Upgrade
|
Quick Ratio | 1.75 | 1.54 | 1.35 | 1.10 | 0.95 | 0.94 | Upgrade
|
Current Ratio | 2.52 | 2.42 | 2.14 | 1.73 | 1.64 | 1.91 | Upgrade
|
Return on Equity (ROE) | 5.55% | 5.68% | 5.49% | 9.71% | 1.93% | 8.82% | Upgrade
|
Return on Assets (ROA) | 3.75% | 3.85% | 3.36% | 2.68% | 1.13% | 0.98% | Upgrade
|
Return on Capital (ROIC) | 4.26% | 4.31% | 3.75% | 2.94% | 1.21% | 1.06% | Upgrade
|
Return on Capital Employed (ROCE) | 6.90% | 7.20% | 6.40% | 5.20% | 2.20% | 1.70% | Upgrade
|
Earnings Yield | 4.35% | 4.72% | 4.04% | 4.99% | 4.33% | 9.37% | Upgrade
|
FCF Yield | 3.83% | 3.91% | 2.07% | 3.13% | 5.16% | 1.47% | Upgrade
|
Dividend Yield | 1.64% | 1.75% | 1.58% | 1.29% | 2.28% | 1.26% | Upgrade
|
Payout Ratio | 32.21% | 33.41% | 32.69% | 18.60% | 26.32% | 7.16% | Upgrade
|
Buyback Yield / Dilution | -2.50% | -3.52% | -3.84% | 0.79% | -2.35% | -9.76% | Upgrade
|
Total Shareholder Return | -0.85% | -1.77% | -2.25% | 2.08% | -0.08% | -8.49% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.